<DOC>
	<DOCNO>NCT01263834</DOCNO>
	<brief_summary>The purpose study evaluate adjunctive effect intratenon Bevacizumab result trabeculectomy primary term intraocular pressure ( IOP ) .</brief_summary>
	<brief_title>Results Adjunctive Intraoperative Bevacizumab Injection Trabeculectomy Outcome</brief_title>
	<detailed_description>Prospective interventional clinical trial Single center , outcome assessor-masked , active control , randomize control trial</detailed_description>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Primary open angle glaucoma primary mmctrabeculectomy indication combine phacoemulsification trabeculectomy 6 month cataract surgery trabeculectomy revise trabeculectomy active uveitic glaucoma neovascular glaucoma par planar vitrectomy conjunctival surgery allergy bevacizumab mitomycin C ischemic heart disease cerebrovascular disease renal failure liver failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Trabeculectomy</keyword>
	<keyword>bevacizumab</keyword>
	<keyword>intraocular pressure</keyword>
</DOC>